We are thrilled that Theramex selected Daré as its development partner for this potentially disruptive long-acting, minimally-invasive contraceptive candidate. The fully funded ongoing Phase 1 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback